![Holly Prentice](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Holly Prentice
Corporate Officer/Principal chez Portage Pharmaceutical Ltd.
Postes actifs de Holly Prentice
Sociétés | Poste | Début | Fin |
---|---|---|---|
Portage Pharmaceutical Ltd.
![]() Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Corporate Officer/Principal | - | - |
Historique de carrière de Holly Prentice
Statistiques
Internationale
Canada | 2 |
Opérationnelle
Corporate Officer/Principal | 1 |
Sectorielle
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Portage Pharmaceutical Ltd.
![]() Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Commercial Services |
- Bourse
- Insiders
- Holly Prentice
- Expérience